InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Korenberg Matthew E, Chief Financial Officer. Insider active across 1 companies, notably Ligand Pharmaceuticals INC. Cumulatively, 6 filings have been logged. The latest transaction was filed on 10 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
08,062 shares0
Common Stock
SEC:0000886163-22-000090:0·
€99,107906 shares@ €109.390.0027% mcap73.5% of flow
Common Stock
SEC:0000886163-22-000021:0·
04,803 shares0
Common Stock
SEC:0000886163-22-000014·
04,803 shares0
Common Stock
SEC:0000886163-22-000014:0·
€17,897247 shares@ €72.45610.0005% mcap100.0% of flow
Common Stock
SEC:0000886163-21-000097·
€17,897247 shares@ €72.45610.0005% mcap13.3% of flow
Common Stock
SEC:0000886163-21-000097:0·
6 of 6 declarations
About Korenberg Matthew E
Matthew E. Korenberg is the Chief Financial Officer and Executive Vice President of Ligand Pharmaceuticals Inc. In this role, he is responsible for the company's financial management, including financial planning and analysis. With a strong background in the pharmaceutical sector, he plays a key role in decision-making that impacts Ligand's performance and growth. His expertise is essential for the company's financial success.
